Development of proprietary unique nM potent agonist of FPR/NOX2
for treatment of autoimmunity, inflammation and infections
Pronoxis have active international collaborations with both academic groups as well as industrial partners.
NATIONWIDE CHILDREN’S HOSPITAL- Kidney and Urinary Tract Research Center
In a research collaboration with Dr. Juan de Dios Ruiz-Rosado and Dr. Brian Becknell within the Kidney and Urinary Tract Research Center at Nationwide Children’s Hospital, Columbus Ohio – we are jointly studying the immunological mechanism of the role of NOX inhibition as a mechanism for treatment of diseases of the kidney and urinary tract.
In this research project led by Dr. Juan de Dios Ruiz-Rosado, we are exploring the potential anti-bacterial properties of Pronoxis FPR specific agonists as potential novel agents to treat urinary tract infections (UTI).